Astrocytes Play Key Role in Alzheimer’s Disease
Researchers have identified the key enzyme causing Alzheimer’s disease by linking it to excessive GABA production in reactive astrocytes.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
Study Aims to Identify New Auditory Biomarkers
The SAPHIR study aims to develop auditory biomarkers for early detection and improved disease management related to cognitive decline.
Dementias & Alzheimer’s
Latest
New Biomarker Tests Enable Early Diagnosis of Synucleinopathies
A new expert-led paper highlights the potential of biomarker testing to improve early diagnosis and treatment of synucleinopathies.
How a Skin Biopsy Can Evaluate Synucleinopathies
A new study demonstrates the clinical utility of a skin biopsy diagnostic tool in improving care for those with neurodegenerative diseases.
Read More
New Blood Test Biomarker Could Detect Dementia Risk Earlier and More Cost-Effectively
Researchers identified a promising blood biomarker for detecting vascular contributions to cognitive impairment and dementia.
Read More
Preparing Your Lab for Blood-Based Alzheimer’s Disease Testing
Blood-based diagnostics for Alzheimer’s disease and other neurological conditions could be here sooner than you think.
Read More
Researchers Explore Reliable Ways to Diagnose Alzheimer’s
Researchers explored how combining CSF analysis and amyloid PET imaging can improve the accuracy and efficiency of Alzheimer’s diagnosis.
Read More
VeraBIND Tau Assay for Alzheimer’s Detection Gets Positive Study Feedback
Study results were revealed for the VeraBIND Tau assay diagnostic test designed to detect active Alzheimer’s disease pathology.
Read More
Finger-Prick Blood Test Could Revolutionize Alzheimer’s Detection
A new capillary blood test offers a simple, mail-in method to detect Alzheimer’s biomarkers, paving the way for accessible global testing.
Read More
Blood Test Detects Parkinson’s Disease Through Alpha Synuclein Biomarkers
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read More
Veravas and Phanes Biotech Partner to Develop Alzheimer’s Tau Pathology Test
Veravas and Phanes Biotech are collaborating to create a blood test using VeraBIND technology to detect Alzheimer’s tau pathology early.
Read More
Roche Presents New Alzheimer’s Disease Diagnostic Data
Roche announced the Elecsys Amyloid Plasma Panel shows promising results in accurately ruling out amyloid pathology in Alzheimer’s disease.
Read More
Olfactory Loss Linked to 100-Plus Diseases
Researchers have found a significant link between olfactory loss in 139 medical conditions, highlighting the role of smell plays.
Read More
New Multi-Marker Blood Test Enhances Alzheimer’s Detection
Lucent Diagnostics launched a blood test using five Alzheimer’s-related biomarkers to improve detection accuracy and reduce invasive testing.
Read More
BrainScope Completes Proof-of-Concept for Early Alzheimer’s Prediction Biomarker
BrainScope completed the proof-of-concept phase for a novel EEG-based biomarker capable of predicting the onset of Alzheimer’s disease.
Read More
Scientists Validate New Lab Test Platform for Alzheimer’s Blood Biomarkers
Scientists have validated a blood test platform that measures over 100 biomarkers related to Alzheimer’s disease.
Read More
Time of Day Impacts Alzheimer’s Biomarker Levels
The time of day significantly affects Alzheimer’s biomarkers, highlighting the need for standardized blood sampling times.
Read More
Revvity Launches APOE Assay for Alzheimer’s Treatment Risk Assessment
Revvity’s APOE assay allows for precise APOE genotyping to assess patient risks before starting anti-amyloid therapy for Alzheimer’s disease.
Read More